Whether cognitive behavioral therapy is effective for Alzheimer's disease A protocol for systematic review and network meta-analysis

被引:1
|
作者
Chen, Wan-Qiang [1 ]
Wu, Fang-Fang [2 ,3 ]
Lv, Hong-Bo [4 ]
Xing, Wen-Ting [1 ]
Liu, Qi [1 ]
Liu, Jun-Ping [1 ]
Ge, Yong-Gui [1 ]
Lu, Ya-Qin [1 ]
机构
[1] Lanzhou Univ, Dept Rehabil, First Hosp, Lanzhou, Gansu, Peoples R China
[2] Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou, Gansu, Peoples R China
[3] Third Peoples Hosp Lan Zhou, WHO Collaborating Ctr Guideline Implementat & Kno, Lanzhou, Gansu, Peoples R China
[4] Third Peoples Hosp Lan Zhou, Dept Sleep, Lanzhou, Gansu, Peoples R China
关键词
alzheimer' s disease; cognitive behavioral therapy; randomized controlled trials; QUALITY; BAPINEUZUMAB; APPRAISAL; DEMENTIA;
D O I
10.1097/MD.0000000000023945
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Alzheimer disease (AD) is a progressive neurodegenerative disease characterized by impaired memory and cognitive judgment. It is the leading cause of dementia in the elderly, and its high morbidity and mortality have also brought a significant social burden. So far, there is no method can completely cure Alzheimer's dementia, but there are many non-drug treatments that have been praised by people, especially the cognitive behavioral therapy proposed in recent years. The main purpose of this article is to evaluate the effect of cognitive behavioral therapy on the cognitive function improvement of patients with Alzheimer's dementia. Methods: We did a network meta-analysis to identify both direct and indirect evidence in relevant studies. A systematic literature search will be performed in the Cochrane Library, PubMed, and EMBASE from inception to October 2020. We extracted the relevant information from these trials with a predefined data extraction sheet and assessed the risk of bias with the Cochrane risk of bias tool. The outcomes investigated were Mini-Mental State Examination and AD Assessment Scale-Cognitive section scores. We did a pair-wise meta-analysis using the fixed-effects model and then did a random-effects network meta-analysis within a Bayesian framework. The = the Assessment of Multiple Systematic Reviews-2 scale, Preferred Reporting Items for Systematic Reviews and Meta-Analyses scale and Grading of Recommendations Assessment, Development and Evaluation were used to assess the quality and evidence grade of the literature. General characteristics of the eligible randomized controlled trials will be summarized and described. Meanwhile, The ADDIS software will be used to perform the network meta-analysis, and the result figures will be generated by STATA 15.0 software. Results: Using the draft search strategy of databases and after screening,7 randomized controlled trials met the a priori criteria and were included. This network mate-analysis will be published in a peer-reviewed journal. Conclusion: Our study will provide evidence for cognitive behavioral intervention in AD patients. And provide recommendations and guidelines for the clinic. Protocol Registration: INPLASY2020110052.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Exercise interventions for older adults with Alzheimer's disease: a systematic review and meta-analysis protocol
    Faieta, Julie M.
    Devos, Hannes
    Vaduvathiriyan, Prasanna
    York, Michele K.
    Erickson, Kirk I.
    Hirsch, Mark A.
    Downer, Brian G.
    van Wegen, Erwin E. H.
    Wong, Diana C.
    Philippou, Elena
    Negm, Ahmed
    Ahmadnezhad, Pedram
    Krishnan, Shilpa
    Kahya, Melike
    Sood, Pallavi
    Heyn, Patricia C.
    [J]. SYSTEMATIC REVIEWS, 2021, 10 (01)
  • [32] Exercise interventions for older adults with Alzheimer’s disease: a systematic review and meta-analysis protocol
    Julie M. Faieta
    Hannes Devos
    Prasanna Vaduvathiriyan
    Michele K. York
    Kirk I. Erickson
    Mark A. Hirsch
    Brian G. Downer
    Erwin E. H. van Wegen
    Diana C. Wong
    Elena Philippou
    Ahmed Negm
    Pedram Ahmadnezhad
    Shilpa Krishnan
    Melike Kahya
    Pallavi Sood
    Patricia C. Heyn
    [J]. Systematic Reviews, 10
  • [33] Intravenous immunoglobulins for Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease: A systematic review with meta-analysis
    Liu, Jia
    Wang, Lu-Ning
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (06) : 475 - 480
  • [34] Periodontal disease and the risk of Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis
    Hu, Xin
    Zhang, Jing
    Qiu, Yulan
    Liu, Zhaonan
    [J]. PSYCHOGERIATRICS, 2021, 21 (05) : 813 - 825
  • [35] Research Criteria for the Behavioral Variant of Alzheimer Disease A Systematic Review and Meta-analysis
    Ossenkoppele, Rik
    Singleton, Ellen H.
    Groot, Colin
    Dijkstra, Anke A.
    Eikelboom, Willem S.
    Seeley, William W.
    Miller, Bruce
    Laforce, Robert, Jr.
    Scheltens, Philip
    Papma, Janne M.
    Rabinovici, Gil D.
    Pijnenburg, Yolande A. L.
    [J]. JAMA NEUROLOGY, 2022, 79 (01) : 48 - 60
  • [36] Systematic Review and Network Meta-analysis of Cognitive and/or Behavioral Therapies (CBT) for Tinnitus
    Landry, Evie C.
    Sandoval, Xochitl Citlalli Romo
    Simeone, Calla N.
    Tidball, Glynnis
    Lea, Jane
    Westerberg, Brian D.
    [J]. OTOLOGY & NEUROTOLOGY, 2020, 41 (02) : 153 - 166
  • [37] COGNITIVE AND NEUROPSYCHIATRIC EFFECTS OF NORADRENERGIC TREATMENT IN ALZHEIMER'S DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS
    Kallweit, Ulf
    Winter, Yaroslav
    Kotterba, Sylvia
    Benes, Heike
    Burghaus, Lothar
    Koch, Andreas
    Girfoglio, Daniela
    Setanoians, Melinda
    Mayer, Geert
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [38] Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer's disease: systematic review and meta-analysis
    David, Michael C. B.
    Del Giovane, Martina
    Liu, Kathy Y.
    Gostick, Benjamin
    Rowe, James Benedict
    Oboh, Imafidon
    Howard, Robert
    Malhotra, Paresh A.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (10): : 1080 - 1090
  • [39] Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis
    Ge, Yi-Jun
    Xu, Wei
    Ou, Ya-Nan
    Qu, Yi
    Ma, Ya-Hui
    Huang, Yu-Yuan
    Shen, Xue-Ning
    Chen, Shi-Dong
    Tan, Lan
    Zhao, Qian-Hua
    Yu, Jin-Tai
    [J]. AGEING RESEARCH REVIEWS, 2021, 69
  • [40] Efficacy of cognitive behavioral therapy for anxiety and depression in Parkinson's disease patients: an updated systematic review and meta-analysis
    Alnajjar, Asmaa Zakria
    Abouelmagd, Moaz Elsayed
    Krayim, Abdulrahman
    AbdelMeseh, Maickel
    Bushara, Nagham
    Nabil, Yehia
    [J]. NEUROLOGICAL SCIENCES, 2024,